0001181431-14-029918.txt : 20140821 0001181431-14-029918.hdr.sgml : 20140821 20140821194750 ACCESSION NUMBER: 0001181431-14-029918 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140819 FILED AS OF DATE: 20140821 DATE AS OF CHANGE: 20140821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc CENTRAL INDEX KEY: 0001302573 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383572512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-995-8200 MAIL ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAKIANATHAN DEEPIKA CENTRAL INDEX KEY: 0001270734 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35993 FILM NUMBER: 141058686 MAIL ADDRESS: STREET 1: 3000 SAND HILL RD, BLDG 1, STE 135 STREET 2: C/O DELPHI VENTURES CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 rrd414996.xml OMED FORM 4 PURCHASES X0306 4 2014-08-19 0 0001302573 OncoMed Pharmaceuticals Inc OMED 0001270734 PAKIANATHAN DEEPIKA C/O DELPHI VENTURES 3000 SAND HILL ROAD, #1-135 MENLO PARK CA 94025 1 0 0 0 Common Stock 2014-08-19 4 P 0 12425 18.8892 A 1924570 I By Delphi Ventures VIII, L.P. Common Stock 2014-08-19 4 P 0 116 18.8892 A 18310 I By Delphi BioInvestments VIII, L.P. Common Stock 2014-08-20 4 P 0 45630 18.9973 A 1970200 I By Delphi Ventures VIII, L.P. Common Stock 2014-08-20 4 P 0 429 18.9973 A 18739 I By Delphi BioInvestments VIII, L.P. Common Stock 2014-08-21 4 P 0 21402 18.9782 A 1991602 I By Delphi Ventures VIII, L.P. Common Stock 2014-08-21 4 P 0 201 18.9782 A 18940 I By Delphi BioInvestments VIII, L.P. The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP VIII"), the general partner of each of Delphi Ventures VIII, L.P. and Delphi BioInvestments VIII, L.P. (collectively, the "Delphi VIII Funds"). As a managing member of DMP VIII, the Reporting Person shares voting and dispositive power over the shares held by the Delphi VIII Funds and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such shares held by the Delphi VIII Funds, except to the extent of her proportionate pecuniary interest therein. /s/ Matthew T. Potter, Attorney-in-Fact for Deepika R. Pakianathan 2014-08-21